DENVER, March 6, 2006 (PRIMEZONE) -- Medical International Technology Inc. announced today that it has received another order from its Malaysian Distributor, ``Rhone Ma Malaysia,'' and has shipped an additional 10 units of its patented AGRO-JET Needle Free Injector. The units will be used in both the pork and poultry industries.

The patented AGRO-JET Needle Free Injector has proven to eliminate cross contamination in poultry inoculations, due to its non-invasive technique. The current method of inoculating poultry throughout most of the world is done via the needle/syringe method. This method typically has several hundred birds inoculated with the same needle before it is discarded. The result is a dramatic increase in the cross-contamination risk between injected birds as well as an increase in the risk of infecting the person performing the injections via potential needle stick injury.

With the H5N1 bird flu rampant in parts of Asia and spreading on a global scale, the non-invasive Needle Free Injectors are catching the attention of many institutions in the poultry and farm animal sectors. Medical International Technologies has proven that their non-invasive technique is more effective in inoculating birds and animals, and is safer for both animals and humans alike. With the fact that AGRO-JET can safely inoculate as many as 800 birds an hour makes the system safer and more cost effective in every way than the current needle/syringe type methods.

 On Behalf of the Board of Directors
 Medical International Technology, Inc.
 Karim Menassa, President

About Medical International Technology, Inc. (http://www.mitcanada.ca)

MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K Medical International Technology, Inc. takes no obligation to update or correct forward-looking statements.

The Medical International Technology, Inc. logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=2204.

Contact:
         Medical International Technology, Inc.
         Business Inquiries:
         Karim Menassa, President and CEO
         (514) 339-9355
        
         AGORA Investor Relations
         Investor Relations Inquiries:
         MDLH@agoracom.com
         www.mitcanada.ca  
         www.agoracom.com/IR/MIT

Source: Medical International Technology, Inc.